8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)
Published . Updated .
8-K - First Tracks Biotherapeutics filed an 8-K with the SEC on Oct 20 (a notice of a material company event).
Directly affected
- TRAX First Tracks Biotherapeutics+9.5%
Named in this report.
Indirectly affected
- SPY SPDR S&P 500+1.6%
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond-1.8%
Long-term U.S. government bonds
- QQQ Invesco QQQ+2.3%
Large technology stocks
- GLD SPDR Gold Shares-3.3%
Gold can move with the broad market
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TRAX | -17.38% | -16.49% | base | +3.51% | +4.55% | after close | after close |
| SPY | +0.07% | -0.75% | base | +0.53% | -0.66% | after close | after close |
| TLT | -1.55% | -0.11% | base | +0.15% | +2.01% | after close | after close |
| QQQ | +1.64% | -1.03% | base | +1.12% | -1.76% | after close | after close |
| GLD | -0.45% | +1.15% | base | +0.34% | -2.28% | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-20 AccNo: 0001193125-26-426666 Size: 446 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 20 Oct 2026: First Tracks Biotherapeutics (TRAX) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +0.34% | final price |
| GLD | the next day | -2.28% | final price |
| GLD | three days earlier | +1.15% | final price |
| GLD | five days earlier | -0.45% | final price |
| QQQ | that day | +1.12% | final price |
| QQQ | the next day | -1.76% | final price |
| QQQ | three days earlier | -1.03% | final price |
| QQQ | five days earlier | +1.64% | final price |
| SPY | that day | +0.53% | final price |
| SPY | the next day | -0.66% | final price |
| SPY | three days earlier | -0.75% | final price |
| SPY | five days earlier | +0.07% | final price |
| TLT | that day | +0.15% | final price |
| TLT | the next day | +2.01% | final price |
| TLT | three days earlier | -0.11% | final price |
| TLT | five days earlier | -1.55% | final price |
| First Tracks Biotherapeutics (TRAX) | that day | +3.51% | final price |
| First Tracks Biotherapeutics (TRAX) | the next day | +4.55% | final price |
| First Tracks Biotherapeutics (TRAX) | three days earlier | -16.49% | final price |
| First Tracks Biotherapeutics (TRAX) | five days earlier | -17.38% | final price |
Who gains and who loses around First Tracks Biotherapeutics (TRAX)
Companies carried with this story
- TRAX First Tracks Biotherapeutics
In “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer),” First Tracks Biotherapeutics (TRAX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TRAX
First Tracks Biotherapeutics (TRAX)
On 20 Oct 2026, “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)” is the story that connects First Tracks Biotherapeutics (TRAX) to this story.
What ties First Tracks Biotherapeutics (TRAX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> TRAX
The price range for First Tracks Biotherapeutics (TRAX), and the dates in the story
TRAX traded between 30.37 and 42.90 across 20 sessions. The latest close on file is 42.74.
How strong the case is around First Tracks Biotherapeutics (TRAX)
44 out of 100
“8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)” scores 44 out of 100. The score uses 1 sources, a +5.21% difference versus the S&P 500 (SPY), and 1 linked companies.